PETER JINDRA to Disease-Free Survival
This is a "connection" page, showing publications PETER JINDRA has written about Disease-Free Survival.
Connection Strength
0.231
-
Analysis of a Genetic Polymorphism in the Costimulatory?Molecule TNFSF4 with Hematopoietic Stem?Cell?Transplant Outcomes. Biol Blood Marrow Transplant. 2016 Jan; 22(1):27-36.
Score: 0.102
-
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients = 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83.
Score: 0.084
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.023
-
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81.
Score: 0.022